Healthsouth Corp. (HLS) Tops Q2 EPS by 34c, Raises FY14 Guidance

Healthsouth Corp. (NYSE: HLS) reported Q2 EPS of $0.81, $0.34 better than the analyst estimate of $0.47. Revenue for the quarter came in at $604.4 million versus the consensus estimate of $588.94 million.

Healthsouth Corp. sees FY2014 EPS of $2.25-$2.31, versus prior guidance of $1.86-$1.91 and the consensus of $1.91. It raised full-year 2014 Adjusted EBITDA guidance to a range of $570 million to $580 million from a range of $555 million to $565 million.

For earnings history and earnings-related data on Healthsouth Corp. (HLS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Diana Shipping withdraws bid to acquire Genco Shipping